Viganò L - Search Results

1

Targeting TRAIL agonistic receptors for cancer therapy.

Carlo-Stella C, Lavazza C, Locatelli A, Viganò L, Gianni AM, Gianni L. Carlo-Stella C, et al. Among authors: vigano l. Clin Cancer Res. 2007 Apr 15;13(8):2313-7. doi: 10.1158/1078-0432.CCR-06-2774. Clin Cancer Res. 2007. PMID: 17438088 Review.

2

Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials.

Gianni L, Viganò L, Surbone A, Ballinari D, Casali P, Tarella C, Collins JM, Bonadonna G. Gianni L, et al. Among authors: vigano l. J Natl Cancer Inst. 1990 Mar 21;82(6):469-77. doi: 10.1093/jnci/82.6.469. J Natl Cancer Inst. 1990. PMID: 2313718

3

Role of daunosamine and hydroxyacetyl side chain in reaction with iron and lipid peroxidation by anthracyclines.

Gianni L, Viganò L, Lanzi C, Niggeler M, Malatesta V. Gianni L, et al. Among authors: vigano l. J Natl Cancer Inst. 1988 Sep 21;80(14):1104-11. doi: 10.1093/jnci/80.14.1104. J Natl Cancer Inst. 1988. PMID: 3137359

4

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.

Gianni L, Kearns CM, Giani A, Capri G, Viganó L, Lacatelli A, Bonadonna G, Egorin MJ. Gianni L, et al. Among authors: vigano l. J Clin Oncol. 1995 Jan;13(1):180-90. doi: 10.1200/JCO.1995.13.1.180. J Clin Oncol. 1995. PMID: 7799018 Clinical Trial.

5

Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.

Gianni L, Viganò L, Locatelli A, Capri G, Giani A, Tarenzi E, Bonadonna G. Gianni L, et al. Among authors: vigano l. J Clin Oncol. 1997 May;15(5):1906-15. doi: 10.1200/JCO.1997.15.5.1906. J Clin Oncol. 1997. PMID: 9164201

6

Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.

Sparreboom A, Verweij J, van der Burg ME, Loos WJ, Brouwer E, Viganò L, Locatelli A, de Vos AI, Nooter K, Stoter G, Gianni L. Sparreboom A, et al. Among authors: vigano l. Clin Cancer Res. 1998 Aug;4(8):1937-42. Clin Cancer Res. 1998. PMID: 9717822

7

Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer.

Grasselli G, Viganò L, Capri G, Locatelli A, Tarenzi E, Spreafico C, Bertuzzi A, Giani A, Materazzo C, Cresta S, Perotti A, Valagussa P, Gianni L. Grasselli G, et al. Among authors: vigano l. J Clin Oncol. 2001 Apr 15;19(8):2222-31. doi: 10.1200/JCO.2001.19.8.2222. J Clin Oncol. 2001. PMID: 11304775 Clinical Trial.

8

Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapy.

Vigano L, Locatelli A, Grasselli G, Gianni L. Vigano L, et al. Invest New Drugs. 2001 May;19(2):179-96. doi: 10.1023/a:1010691218625. Invest New Drugs. 2001. PMID: 11392452 Review.

9

Mechanism-based pharmacokinetic model for paclitaxel.

Henningsson A, Karlsson MO, Viganò L, Gianni L, Verweij J, Sparreboom A. Henningsson A, et al. Among authors: vigano l. J Clin Oncol. 2001 Oct 15;19(20):4065-73. doi: 10.1200/JCO.2001.19.20.4065. J Clin Oncol. 2001. PMID: 11600609 Clinical Trial.

10

Anthracyclines.

Gianni L, Grasselli G, Cresta S, Locatelli A, Viganò L, Minotti G. Gianni L, et al. Among authors: vigano l. Cancer Chemother Biol Response Modif. 2002;20:59-69. Cancer Chemother Biol Response Modif. 2002. PMID: 12703200 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters